{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:44:06Z","timestamp":1788371046932,"version":"build-2803163510"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":526,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to explore the causal relationships between cathepsins and cardiovascular diseases (CVDs) by Mendelian randomization (MR) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Single nucleotide polymorphisms (SNPs) associated with nine cathepsin types (cathepsins B, E, F, G, H, O, S, L2, and Z) were obtained from the INTERVAL study (3301 individuals). CVDs data were acquired from the UK Biobank (coronary atherosclerosis: 14 334 cases, 346 860 controls) and a genome-wide association study (GWAS) (myocardial infarction: 20 917 cases, 440 906 controls; myocarditis: 633 cases, 427 278 controls; chronic heart failure: 14 262 cases, 471 898 controls; angina pectoris: 30 025 cases, 440 906 controls; stable angina pectoris: 17 894 cases, 325 132 controls; unstable angina pectoris: 9481 cases, 446 987 controls; pericarditis: 1795 cases, 453 370 controls). Inverse variance weighted (IVW), MR-Egger, weighted median methods were adopted to conduct univariable MR (UVMR), reverse MR, multivariable MR (MVMR) analyses to estimate causality. The UVMR analyses demonstrated significant causal relationships between higher cathepsin E levels and increased risk of coronary atherosclerosis [IVW: P = 0.0051, odds ratio (OR) = 1.0033, 95% confidence interval (CI) = 1.0010\u20131.0056] and myocardial infarction (IVW: P = 0.0097, OR = 1.0553, 95% CI = 1.0131\u20131.0993), while elevated cathepsin L2 levels were causally related to reduced risk of myocarditis (IVW: P = 0.0120, OR = 0.6895, 95% CI = 0.5158\u20130.9216) and chronic heart failure (IVW: P = 0.0134, OR = 0.9316, 95% CI = 0.8807\u20130.9854). Reverse MR analyses revealed that myocardial infarction increased cathepsin O levels (IVW: P = 0.0400, OR = 1.0708, 95% CI = 1.0031\u20131.1431). MVMR analyses treating nine cathepsins together revealed that the positive causality between cathepsin E levels and coronary atherosclerosis risk (IVW: P = 0.0390, OR = 1.0030, 95% CI = 1.0000\u20131.0060), and the protective effect of cathepsin L2 levels on myocarditis (IVW: P = 0.0030, OR = 0.6610, 95% CI = 0.5031\u20130.8676) and chronic heart failure (IVW: P = 0.0090, OR = 0.9259, 95% CI = 0.8737\u20130.9812) remained, as higher cathepsin O levels were found to be causally related to increased risks of myocarditis (IVW: P = 0.0030, OR = 1.6145, 95% CI = 1.1829\u20132.2034) and chronic heart failure (IVW: P = 0.0300, OR = 1.0779, 95% CI = 1.0070\u20131.1537).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study highlights the causalities of cathepsin E, L2, and O on CVDs, offering insights into their roles in cardiovascular biomarkers and therapeutic targets development. Further research is required to apply these genetic findings clinically.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14826","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T21:13:45Z","timestamp":1715116425000},"page":"2707-2718","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genetic Insights into the Role of Cathepsins in Cardiovascular Diseases: A Mendelian Randomization Study"],"prefix":"10.1093","volume":"11","author":[{"given":"Ruiqi","family":"Zeng","sequence":"first","affiliation":[{"name":"Guangzhou Medical University , Guangzhou, 511436 ,","place":["China"]},{"name":"Department of Clinical Medicine, Nanshan College, Guangzhou Medical University , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Guangzhou Medical University , Guangzhou, 511436 ,","place":["China"]},{"name":"Department of Clinical Medicine, Third Clinical School, Guangzhou Medical University , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhe","family":"Liao","sequence":"additional","affiliation":[{"name":"Guangzhou Medical University , Guangzhou, 511436 ,","place":["China"]},{"name":"Department of Clinical Medicine, Nanshan College, Guangzhou Medical University , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beian","family":"Guo","sequence":"additional","affiliation":[{"name":"Guangzhou Medical University , Guangzhou, 511436 ,","place":["China"]},{"name":"Department of Clinical Medicine, Nanshan College, Guangzhou Medical University , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"2026012113131758400_ehf214826-bib-0001","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.gheart.2016.10.024","article-title":"The global burden of disease study and the preventable burden of NCD","volume":"11","author":"Benziger","year":"2016","journal-title":"Global heart"},{"key":"2026012113131758400_ehf214826-bib-0002","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCOUTCOMES.115.002007","article-title":"Ischemic heart disease worldwide, 1990 to 2013: estimates from the Global Burden of Disease study 2013","volume":"8","author":"Shepard","year":"2015","journal-title":"Circul: Cardiovasc Qual Outcomes"},{"key":"2026012113131758400_ehf214826-bib-0003","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","volume":"28","author":"Bragazzi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026012113131758400_ehf214826-bib-0004","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.bbagen.2014.03.017","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"1840","author":"Fonovi\u0107","year":"2014","journal-title":"Biochim Biophys Acta (BBA)-general subjects"},{"key":"2026012113131758400_ehf214826-bib-0005","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.biochi.2007.07.024","article-title":"Cysteine cathepsins: cellular roadmap to different functions","volume":"90","author":"Brix","year":"2008","journal-title":"Biochimie"},{"key":"2026012113131758400_ehf214826-bib-0006","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2026012113131758400_ehf214826-bib-0007","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1172\/jci42918","article-title":"Specialized roles for cysteine cathepsins in health and disease","volume":"120","author":"Reiser","year":"2010","journal-title":"J Clin Invest"},{"key":"2026012113131758400_ehf214826-bib-0008","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2013.01.004","article-title":"Circulating cathepsin K as a potential novel biomarker of coronary artery disease","volume":"228","author":"Cheng","year":"2013","journal-title":"Atherosclerosis"},{"key":"2026012113131758400_ehf214826-bib-0009","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/atvbaha.109.194613","article-title":"Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging","volume":"30","author":"Kim","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026012113131758400_ehf214826-bib-0010","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.atherosclerosis.2005.08.001","article-title":"Increased serum cathepsin S in patients with atherosclerosis and diabetes","volume":"186","author":"Liu","year":"2006","journal-title":"Atherosclerosis"},{"key":"2026012113131758400_ehf214826-bib-0011","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.atherosclerosis.2005.05.012","article-title":"Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells","volume":"184","author":"Liu","year":"2006","journal-title":"Atherosclerosis"},{"key":"2026012113131758400_ehf214826-bib-0012","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1177\/2047487319893042","article-title":"Cathepsin B expression is associated with arterial stiffening and atherosclerotic vascular disease","volume":"27","author":"Mareti","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026012113131758400_ehf214826-bib-0013","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","article-title":"Clinical and prognostic significance of sST2 in heart failure: JACC review topic of the week","volume":"74","author":"Aimo","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012113131758400_ehf214826-bib-0014","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s00059-015-4311-6","article-title":"Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI","volume":"40","author":"Yamac","year":"2015","journal-title":"Herz"},{"key":"2026012113131758400_ehf214826-bib-0015","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136093","article-title":"Increased circulating cathepsin K in patients with chronic heart failure","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS ONE"},{"key":"2026012113131758400_ehf214826-bib-0016","first-page":"4","volume-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","author":"Burgess","year":"2019"},{"key":"2026012113131758400_ehf214826-bib-0017","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Human Mol Gen"},{"key":"2026012113131758400_ehf214826-bib-0018","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume-title":"Mendelian randomization","author":"Emdin","year":"2017"},{"key":"2026012113131758400_ehf214826-bib-0019","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"2026012113131758400_ehf214826-bib-0020","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"2026012113131758400_ehf214826-bib-0021","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10654-020-00622-7","article-title":"Mendel's laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues","volume":"35","author":"Davey Smith","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"2026012113131758400_ehf214826-bib-0022","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype\u2013phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"2026012113131758400_ehf214826-bib-0023","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Gen"},{"key":"2026012113131758400_ehf214826-bib-0024","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2026012113131758400_ehf214826-bib-0025","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Gen Epidemiol"},{"key":"2026012113131758400_ehf214826-bib-0026","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Gen Epidemiol"},{"key":"2026012113131758400_ehf214826-bib-0027","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2026012113131758400_ehf214826-bib-0028","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"elife"},{"key":"2026012113131758400_ehf214826-bib-0029","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"2026012113131758400_ehf214826-bib-0030","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"Mendelian randomization: an R package for performing Mendelian randomization analyses using summarized data","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2026012113131758400_ehf214826-bib-0031","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2026012113131758400_ehf214826-bib-0032","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Gen"},{"key":"2026012113131758400_ehf214826-bib-0033","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1002\/sim.9133","article-title":"Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization","volume":"40","author":"Sanderson","year":"2021","journal-title":"Stat Med"},{"key":"2026012113131758400_ehf214826-bib-0034","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038984","article-title":"Multivariable Mendelian randomization and mediation","volume":"11","author":"Sanderson","year":"2021","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"2026012113131758400_ehf214826-bib-0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2020.140360","article-title":"Cysteinyl cathepsins in cardiovascular diseases","volume":"1868","author":"Zhang","year":"2020","journal-title":"Biochim Biophys (BBA)-Proteins Proteomics"},{"key":"2026012113131758400_ehf214826-bib-0036","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1096\/fj.06-7924com","article-title":"Cathepsin cysteine proteases in cardiovascular disease","volume":"21","author":"Lutgens","year":"2007","journal-title":"FASEB Journal"},{"key":"2026012113131758400_ehf214826-bib-0037","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","article-title":"Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials","volume":"15","author":"Liu","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2026012113131758400_ehf214826-bib-0038","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/febs.14043","article-title":"Cysteine proteases in atherosclerosis","volume":"284","author":"Weiss-Sadan","year":"2017","journal-title":"FEBS Journal"},{"key":"2026012113131758400_ehf214826-bib-0039","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5551\/jat.RV17016","article-title":"Cysteine protease cathepsins in atherosclerotic cardiovascular diseases","volume":"25","author":"Wu","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"2026012113131758400_ehf214826-bib-0040","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1126\/science.280.5362.450","article-title":"Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus","volume":"280","author":"Nakagawa","year":"1998","journal-title":"Science"},{"key":"2026012113131758400_ehf214826-bib-0041","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2026012113131758400_ehf214826-bib-0042","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10741-011-9269-8","article-title":"Role of various proteases in cardiac remodeling and progression of heart failure","volume":"17","author":"M\u00fcller","year":"2012","journal-title":"Heart Fail Rev"},{"key":"2026012113131758400_ehf214826-bib-0043","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00109-008-0423-2","article-title":"Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT\/GSK3beta signaling","volume":"87","author":"Tang","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"2026012113131758400_ehf214826-bib-0044","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/s0828-282x(06)70315-4","article-title":"Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies","volume":"22","author":"Machackova","year":"2006","journal-title":"Can J Cardiol"},{"key":"2026012113131758400_ehf214826-bib-0045","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.113.000191","article-title":"Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways","volume":"2","author":"Sun","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026012113131758400_ehf214826-bib-0046","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1152\/physiol.00041.2007","article-title":"Signaling in muscle atrophy and hypertrophy","volume":"23","author":"Sandri","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"2026012113131758400_ehf214826-bib-0047","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","article-title":"Toxic proteins released from mitochondria in cell death","volume":"23","author":"Saelens","year":"2004","journal-title":"Oncogene"},{"key":"2026012113131758400_ehf214826-bib-0048","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1074\/jbc.M008944200","article-title":"Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route","volume":"276","author":"Stoka","year":"2001","journal-title":"J Biol Chem."},{"key":"2026012113131758400_ehf214826-bib-0049","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1084\/jem.184.2.485","article-title":"Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL","volume":"184","author":"Alexander-Miller","year":"1996","journal-title":"J Exp Med"},{"key":"2026012113131758400_ehf214826-bib-0050","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.4049\/jimmunol.163.4.1817","article-title":"Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells","volume":"163","author":"Kishimoto","year":"1999","journal-title":"J Immunol"},{"key":"2026012113131758400_ehf214826-bib-0051","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coi.2005.11.011","article-title":"Endosomal proteases in antigen presentation","volume":"18","author":"Chapman","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"2026012113131758400_ehf214826-bib-0052","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1097\/hjh.0000000000002456","article-title":"Adaptive immune disorders in hypertension and heart failure: focusing on T-cell subset activation and clinical implications","volume":"38","author":"Rai","year":"2020","journal-title":"J Hypertens"},{"key":"2026012113131758400_ehf214826-bib-0053","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0019-4832(12)60089-3","article-title":"Levels of cathepsins in acute myocardial infarction","volume":"64","author":"Shalia","year":"2012","journal-title":"Indian Heart J"},{"key":"2026012113131758400_ehf214826-bib-0054","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jacc.2022.05.055","article-title":"Cathepsin s levels and survival among patients with non-st-segment elevation acute coronary syndromes","volume":"80","author":"Stamatelopoulos","year":"2022","journal-title":"J Am Coll Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/5\/2707\/64516019\/eschf_11_5_2707.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/5\/2707\/64516019\/eschf_11_5_2707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:15:01Z","timestamp":1769019301000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/5\/2707\/8271129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,7]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14826","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"2024-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}